Literature DB >> 3029448

The in vivo cardiotoxic effect of eosinophilic cationic protein in an animal preparation.

C Kishimoto, C J Spry, P C Tai, N Tomioka, C Kawai.   

Abstract

We studied the in vivo effects of eosinophilic cationic protein (ECP) on DBA/2 mice, and compared the cardiac lesions caused by ECP with those caused by encephalomyocarditis (EMC) virus. ECP caused myocarditis in two of five mice (40%), and EMC virus did so in five of five mice (100%). Cardiac lesions of ECP were mild and limited to the right ventricular wall, which differed from those in the mice with EMC virus inoculation, where both the right and left ventricles were involved. This experiment is the first demonstration of the in vivo cardiotoxicity of ECP.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3029448     DOI: 10.1253/jcj.50.1264

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  4 in total

Review 1.  The pathogenesis of endomyocardial fibrosis: the role of the eosinophil.

Authors:  C J Spry
Journal:  Springer Semin Immunopathol       Date:  1989

2.  Effects of monoclonal antibodies to adhesion molecules on eosinophilic myocarditis in Toxocara canis-infected CBA/J mice.

Authors:  S Hokibara; M Takamoto; M Isobe; K Sugane
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

3.  Control of hypereosinophilic syndrome-associated recalcitrant coronary artery spasm by combined treatment with prednisone, imatinib mesylate and hydroxyurea.

Authors:  Joseph H Butterfield; Scott W Sharkey
Journal:  Exp Clin Cardiol       Date:  2006

Review 4.  Diagnosis and treatment of eosinophilic myocarditis.

Authors:  Zezhong Zhong; Zicong Yang; Yiming Peng; Lei Wang; Xuming Yuan
Journal:  J Transl Autoimmun       Date:  2021-09-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.